Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Biohaven Q2 Adj. EPS $(1.63) Beats $(1.72) Estimate; Cash $408.2M

Author: Benzinga Newsdesk | August 11, 2025 07:10am

Biohaven (NYSE:BHVN) reported quarterly losses of $(1.63) per share which beat the analyst consensus estimate of $(1.72) by 5.23 percent. This is a 53.43 percent increase over losses of $(3.50) per share from the same period last year.

Cash, cash equivalents, marketable securities and restricted cash as of June 30, 2025, totaled approximately $408.2 million

Posted In: BHVN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist